speb/financial-data huggingface dataset:
GENCON.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1978493000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1978493000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 743005000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 743005000.00
GENCON.NS income_statement (annual, 2026-03-31) — Gross Profit: 483408000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 89151000.00
GENCON.NS income_statement (annual, 2026-03-31) — Interest Expense: 109470000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 19920000.00
GENCON.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 109470000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 19920000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -102147000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 7906000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Inventory: 782920000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 782920000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 3504051000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3504051000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -136503000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 113607000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 113607000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 190767000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 190767000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
GENCON.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 13886000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 41063000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 41063000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 3193000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3193000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 44256000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 44256000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 13886000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -13719000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 3373000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 3373000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Net Debt: 530736000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 530736000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income: 18903000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 18903000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 18903000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 18903000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 18903000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 142018000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 18903000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Interest Income: -109470000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -19920000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -32946000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 37844000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 167000.00
GENCON.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -109470000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -19920000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 13530000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Net PPE: 743005000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 743005000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -126993000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 37677000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2757314000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2757314000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 26310000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 26310000.00
GENCON.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 390292000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 93051000.00
GENCON.NS income_statement (annual, 2026-03-31) — Normalized Income: 85046000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 18903000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 236136000.00
GENCON.NS income_statement (annual, 2026-03-31) — Operating Income: 204550000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Operating Income: 40508000.00
GENCON.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3053653000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1112230000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 56986219.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 56986219.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 618702000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 618702000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 136218000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 136218000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 88034000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1000.00
GENCON.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 46938000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 17858000.00
GENCON.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 114925000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 8897000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Properties: 743005000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 743005000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 104516000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 104516000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 388551000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 388551000.00
GENCON.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Payables: 1140883000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1140883000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 1499000.00
GENCON.NS income_statement (annual, 2026-03-31) — Pretax Income: 142018000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 38446000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
GENCON.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -51722000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -126993000.00
GENCON.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2570245000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1023079000.00
GENCON.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 138804000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 34685000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -13719000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 18776000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Share Issued: 56986219.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 56986219.00
GENCON.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2930024000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2930024000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2757314000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2757314000.00
GENCON.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GENCON.NS income_statement (annual, 2026-03-31) — Tax Provision: 56962000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 19540000.00
GENCON.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
GENCON.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
GENCON.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 17302000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 17302000.00
GENCON.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -51818000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5180175000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5180175000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2933217000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2933217000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Debt: 642760000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 642760000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 2930024000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2930024000.00
GENCON.NS income_statement (annual, 2026-03-31) — Total Expenses: 2849103000.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1071722000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2250151000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2250151000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1246400000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1246400000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 54229000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 54229000.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
GENCON.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
GENCON.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GENCON.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GENCON.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1737853000.00
GENCON.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1737853000.00
GENESYS.NS income_statement (annual, 2022-03-31) — +Operating Expense: 265991000.00
GENESYS.NS income_statement (annual, 2022-03-31) — +Total Revenue: 1165103000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 239840000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 491460000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -882315000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 526517000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -33424000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 27386000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 31247559.00
GENESYS.NS income_statement (annual, 2022-03-31) — Basic EPS: 4.28
GENESYS.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 13815000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 124103000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -331369000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 63037000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 156814000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 213809000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 275681000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 1006000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 213809000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -194325000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 269656000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Change In Payable: 131893000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -170283000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 36941000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 199994000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Common Stock: 156814000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 2048084000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 33827000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 59927000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 806680000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Assets: 1280360000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 34998000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Debt: 188707000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 223705000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 730531000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 22947000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Depreciation: 191257000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 191257000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 191256000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 191256000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 33704335.00
GENESYS.NS income_statement (annual, 2022-03-31) — Diluted EPS: 4.13
GENESYS.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 134115000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 85000.00
GENESYS.NS income_statement (annual, 2022-03-31) — EBIT: -333909000.00
GENESYS.NS income_statement (annual, 2022-03-31) — EBITDA: -142652000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — End Cash Position: 213809000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 119068000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -50217000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -1235000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
GENESYS.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 36961000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 1246808000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 524884000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 1206964000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Gross Profit: 358423000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 0.00
GENESYS.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 0.00
GENESYS.NS income_statement (annual, 2022-03-31) — Interest Expense: 24776000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 24776000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Interest Income: 3083000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 3083000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -19019000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 1824000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 2250050000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -200226000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 0.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 33827000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 28039000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 13259000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 41298000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 59654000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 606826000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 310643000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Minority Interests: 530969000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 33827000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: -11292000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income: 134115000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 134115000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -396854000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 134115000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 134115000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -358685000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -396854000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -141690000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Interest Income: -22994000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 27232000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 135619000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 4858000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -22994000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 6356000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Net PPE: 324649000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -83551000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 130761000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 801276000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 273258000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 59654000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 41644000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 307180000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Normalized Income: 448997400.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 281152000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Operating Income: 92432000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Operating Revenue: 1165103000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 31362752.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 91686000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 26177000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 189407000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 1246808000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -51800000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 2406000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 7130000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 62429000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Payable: 241596000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Properties: 416108000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 434014000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 61872000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Other Special Charges: 451068000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Payables: 483879000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 14165000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 22947000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 70254000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Pretax Income: -358685000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -55725000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -141690000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -386065000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -189679000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 806680000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 191257000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 6534000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 6534000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 8951000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 833058000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 413297000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 106128000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 36961000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Share Issued: 31362752.00
GENESYS.NS income_statement (annual, 2022-03-31) — Special Income Charges: -451068000.00
GENESYS.NS cash_flow (annual, 2022-03-31) — Stock Based Compensation: 14166000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 2048084000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 801276000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -134949600.00
GENESYS.NS income_statement (annual, 2022-03-31) — Tax Provision: 38169000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.30
GENESYS.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -26261000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Assets: 3190210000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 2061343000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Debt: 265003000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2358727000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Total Expenses: 1072671000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 831483000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 1909850000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 100952000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 1301000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 2358000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -449832000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -449832000.00
GENESYS.NS balance_sheet (annual, 2022-03-31) — Working Capital: 549829000.00
GENESYS.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
GENESYS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 635101000.00
GENESYS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1811285000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 222274000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 832194000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -977077000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2573272000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -68351000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Amortization: 239704000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 26491000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 35147151.00
GENESYS.NS income_statement (annual, 2023-03-31) — Basic EPS: 5.44
GENESYS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 213809000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 151056000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -979619000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 69330000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 188775000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 125635000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 640776000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 125635000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -584790000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 16849000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Change In Payable: -20826000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -346715000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -935482000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -88174000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 188775000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4054117000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 2091292000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 75413000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 960544000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2434430000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 24616000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 150418000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 175034000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 690766000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 27324000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Depreciation: 375298000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 375298000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 372090000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 132386000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 36172839.00
GENESYS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 5.29
GENESYS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 190778000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 55000.00
GENESYS.NS income_statement (annual, 2023-03-31) — EBIT: 276617000.00
GENESYS.NS income_statement (annual, 2023-03-31) — EBITDA: 651915000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 125635000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2148594000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1331538000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -23993000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -20000.00
GENESYS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 81610000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1563719000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 900545000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1635893000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Gross Profit: 850741000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 0.00
GENESYS.NS income_statement (annual, 2023-03-31) — Interest Expense: 26661000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 26661000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Interest Income: 3841000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 3841000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -42676000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 4120000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 4377964000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1884849000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 2091292000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 235952000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 44714000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 173429000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 218143000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 235952000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -25951000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 72427000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 789888000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 20751000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Minority Interests: 41460000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -532583000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 2091292000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Net Debt: 198212000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 44320000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income: 190778000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 190778000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 149318000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 190778000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 190778000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 249956000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 149318000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -127731000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -25544000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -377035000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 140017000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 210001000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -25544000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 658816000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -851888000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -69984000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2490398000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 269034000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 72427000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 105094000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 627926000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Normalized Income: 173985700.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -351919000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Operating Income: 215640000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1811285000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 37755099.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 129975000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 30696000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 187761000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1563719000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -58545000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -1000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 4432000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 104733000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 253773000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 619536000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 749018000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 515141000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Other Special Charges: -20000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Payables: 488408000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27324000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 143842000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Pretax Income: 249956000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 34927000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -532583000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -127731000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1807267000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -851888000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 960544000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 375298000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 3305000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 3305000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -25951000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 68600000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 595922000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 1430232000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 81610000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 37755099.00
GENESYS.NS income_statement (annual, 2023-03-31) — Special Income Charges: -4000.00
GENESYS.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 26862000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4054117000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2490398000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 7196700.00
GENESYS.NS income_statement (annual, 2023-03-31) — Tax Provision: 100638000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
GENESYS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -66232000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 5056204000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 4227546000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 393177000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4074868000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Total Expenses: 1595645000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 981336000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2621774000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 290570000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 2724000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 12306000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 23989000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 23989000.00
GENESYS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1743664000.00
GENESYS.NS income_statement (annual, 2023-03-31) — Write Off: 24000.00
GENESYS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 675017000.00
GENESYS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1982429000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 296485000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1426705000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1150902000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 3344148000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -70908000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Amortization: 219451000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 219451000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 74232000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 38160656.00
GENESYS.NS income_statement (annual, 2024-03-31) — Basic EPS: 5.78
GENESYS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 125635000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 233734000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -836494000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 76487000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 197703000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 232674000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 305453000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 59131000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 173543000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -255305000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 111210000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Change In Payable: 93249000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -607322000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -658168000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 107039000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 197703000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4891621000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 585179000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 30290000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 916224000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 3313181000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 26079000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 297326000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 323405000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1088513000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 31972000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Depreciation: 225351000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 444802000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 444802000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 225351000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 38444445.00
GENESYS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 5.74
GENESYS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 220729000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 44000.00
GENESYS.NS income_statement (annual, 2024-03-31) — EBIT: 410849000.00
GENESYS.NS income_statement (annual, 2024-03-31) — EBITDA: 855651000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 232674000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 712433000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -645821000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -11047000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -1551000.00
GENESYS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 72477000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1929261000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1497613000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1938353000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Gross Profit: 1066205000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 0.00
GENESYS.NS income_statement (annual, 2024-03-31) — Interest Expense: 39094000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 39094000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Interest Income: 8758000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 8758000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -39095000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 5709000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 5410312000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -796067000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 585179000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 267157000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 50408000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 221365000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 271773000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 161177000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -72312000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 77962000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 857717000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 16158000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Minority Interests: 4606000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 585179000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Net Debt: 286017000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 10296000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income: 220729000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 220729000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 216123000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 220729000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 220729000.00